Program Information
WHAT WE DO
ai² Futures Lab™ is an experiential learning program that gives students hands-on exposure to real-world challenges in biotechnology and drug development
Working with underdeveloped or distressed therapeutic assets, participants explore how promising science can move forward despite funding, strategic, or pipeline constraints. The program bridges academic training with practical insight, preparing students to engage in translational science and innovation.
From Data to Decisions
Clinical Review
Student teams identify and evaluate deprioritized or distressed clinical assets through a structured, real-world diligence process designed to mirror industry decision-making.
Market Analysis
A deep dive into the commercial potential of the asset, including market sizing, competitive landscape (marketed and developmental), unmet need, and opportunity positioning.
Financial Outlook
Evaluation of the asset’s potential financial profile, including pricing considerations, revenue potential, peak sales forecasting, and projected adoption curves from launch to maturity.
How it works
Students are organized into interdisciplinary teams and guided by industry mentors throughout the program. Each team identifies and evaluates a real therapeutic asset, examining its scientific foundation, clinical potential, and commercial considerations. Through structured analysis, collaboration, and mentorship, participants develop recommendations aimed at navigating the industry’s “Valley of Death” and unlocking value in overlooked innovations.
Ideal Participant Profile
ai² Futures Lab™ is designed for undergraduate and graduate students interested in biotechnology, life sciences, medicine, business, or related fields. The program is well suited for students seeking applied experience, exposure to real-world drug development decision-making, and a deeper understanding of how scientific discoveries translate into therapies with real impact.